Obstructive sleep apnea syndrome (OSAS) and ischemic heart disease (IHD) frequently coexist as comorbid conditions that mutually exacerbate one another. The aim of this review is to evaluate the impact of OSAS on cerebrovascular complications in patients with IHD based on a systematic review of the available literature. Ischemic heart disease (IHD) and sleep disorders, particularly obstructive sleep apnea syndrome (OSAS), represent one of the most significant challenges in contemporary medicine. Over the past decade, substantial evidence has demonstrated that the coexistence of these two conditions constitutes an independent risk factor for the development of cerebrovascular diseases. According to the World Health Organization (WHO), cardiovascular diseases accounted for approximately 31% of all global deaths in 2023. Meanwhile, the global prevalence of OSAS is estimated to range from 15% to 30%, with the condition occurring 2–3 times more frequently in men than in women. Among patients with IHD, the prevalence of OSAS is estimated to reach 40–60%. Cerebrovascular complications, including ischemic stroke, transient ischemic attack (TIA), subcortical leukoencephalopathy, and cognitive impairment, are particularly common in patients with concomitant IHD and OSAS. Pathophysiologically, these complications are associated with hypertension, endothelial dysfunction, oxidative stress, and sympathetic overactivation. However, the precise mechanisms underlying these associations remain incompletely understood.
| Mualliflar | Rakhmanov, Eldor, Mahkamova, Nargiza, Рахманов, Э, Махкамова, Н, Raxmanov, Eldor, Mahkamova, Nargiza |
|---|---|
| Jurnal | O‘zbekiston кardiologiyasi |
| Nashr sanasi | 2026-03-29 |
| Jild | 3 |
| Son | 1 |
| Betlar | 66-74 |
| Til | O‘zbek |
| DOI | 10.70626/cardiouz-2026-3-00079 |
DOI: 10.70626/cardiouz-2026-3-00079 · Maqolaning asl sahifasi
Obstructive sleep apnea syndrome, ischemic heart disease, ischemic stroke, cerebrovascular complications, CPAP, endothelial dysfunction, cognitive impairment, Синдром обструктивного апноэ сна, ишемическая болезнь сердца, ишемический инсульт, цереброваскулярные осложнения, CPAP, эндотелиальная дисфункция, когнитивные нарушения, Obstruktiv uyqu apnoe sindromi, yurak ishemik kasalligi, ishemik insult, serebrovaskulyar asoratlar, CPAP, endotelial disfunksiya, kognitiv buzilishlar
Cardiorenometabolic syndrome (CRMS) is one of the most important challenges in modern medicine and is considered a leading cause of morbidity and mortality worldwide. Major randomized clinical trials conducted over the…
Aim. To determine the extent of quality-of-life (KCCQ-12) recovery over 6 months of treatment in patients with ischemic cardiomyopathy (ICM), its association with the completeness of coronary revascularization, and the…
Sudden cardiac death (SCD) in young individuals is a significant medical and social problem, a substantial proportion of which is caused by inherited disorders of myocardial electrical activity. The aim of this review…
Lipid metabolism disorders are one of the leading risk factors for the development of atherosclerotic cardiovascular diseases and remain of high importance worldwide. Despite substantial advances in reducing low-density…
Cardiorenometabolic syndrome (CRMS) is a multifactorial clinical condition reflecting complex and interrelated pathobiological processes involving the cardiovascular, renal, and metabolic systems. Its central mechanisms…
Chronic coronary syndrome (CCS) remains one of the leading causes of mortality and disability worldwide, particularly in Central Asian countries and the Republic of Uzbekistan. This review presents a contemporary…
Non-obstructive angina and ischemia of the coronary arteries (ANOCA/INOCA) is a condition in which there are signs of angina and/or ischemia in the absence of significant obstruction of the coronary arteries. This…
Patient registries following acute myocardial infarction (AMI) and stroke are a key tool for quality control, real-world clinical practice research, and secondary prevention management. This article examines…
Aim: To evaluate the effect of combined antihypertensive therapy on arterial blood pressure parameters in pregnant women with uncontrolled gestational arterial hypertension. Materials and methods: The study included 60…
Aim. To determine the association between polymorphisms of the PITX2 (rs6817105) and KCNN3 (rs13376333) genes and the development of atrial fibrillation (AF) in patients with arterial hypertension (AH) in the Uzbek…